LS 3X Long Cryptocurrency Fund | Mid-cap

LS 3X Long Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €5.94 High: €6.56
on August 8, 2025

52 Week Range

Low: €1.12 High: €46.30
on April 7, 2025
on November 12, 2024

All-Time High: €121.60 on March 25, 2024

Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights

Key Statistics

Market Cap i €828.6M
EPS i 3.79
P/E Ratio (TTM) i 1.70
Forward P/E i N/A
P/B Ratio i 0.31
PEG Ratio i -0.83
Div. Yield i N/A
ROE i 30.41%
Beta i N/A
Debt to Equity i 1.88

Financial Highlights

Profitability

Gross Margin i 38.53%
Operating Margin i N/A
Profit Margin i 36.27%

Returns and Earnings

Return on Assets (TTM) i 7.27%
Return on Equity (TTM) i 30.41%
EBITDA i €874.7M
Net Income (TTM) i €483.6M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €52.43
Quarterly Revenue Growth (YoY) i -2.60%
Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
LS 3X Long 3CON 828.59M Mid-cap-19.40%-49.66%66.85%-65.61%-62.31%-66.21%-93.25%-91.75%
Corbion N.V CRBN 960.42M Mid-cap0.61%-11.73%-13.44%-26.05%-23.94%-21.56%-47.82%-52.37%
Ferrari Group PLC FERGR 868.23M Mid-cap0.43%0.21%22.15%4.78%4.78%6.55%6.55%6.55%
Wereldhave N.V WHA 842.07M Mid-cap7.45%10.06%13.06%26.93%35.23%36.39%23.40%159.40%
AMG Critical AMG 766.66M Mid-cap-2.49%4.08%21.97%56.12%64.66%54.98%-18.87%42.91%
Pharming Group N.V PHARM 720.78M Mid-cap9.68%15.91%14.61%22.89%6.25%41.67%0.00%-6.42%

Ownership & Short Interest

Insider Ownership i N/A
Institutional Ownership i N/A
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 8K
Average 90-Day Volume i 10K

LS 3X Long Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in LS 3X Long would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, LS 3X Long reached a high of €46.30 (on November 12, 2024) and a low of €1.12 (on April 7, 2025).
Curious about LS 3X Long's size and valuation? Its market capitalization stands at 828.59M. When it comes to valuation, the P/E ratio (trailing twelve months) is 1.70, and the forward P/E (looking ahead) is N/A.
As for dividends, LS 3X Long isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at LS 3X Long, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Corbion N.V
CRBN
960.42MBasic MaterialsSpecialty Chemicals-21.56%-47.82%
Ferrari Group PLC
FERGR
868.23MIndustrialsIntegrated Freight & Logistics6.55%6.55%
Wereldhave N.V
WHA
842.07MReal EstateREIT - Retail36.39%23.40%
AMG Critical
AMG
766.66MBasic MaterialsOther Industrial Metals & Mining54.98%-18.87%
Pharming Group N.V
PHARM
720.78MHealthcareBiotechnology41.67%0.00%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of LS 3X Long's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 30.41%, the Debt to Equity ratio from the most recent quarter is 1.88, and its Gross Profit Margin stands at 38.53%.
Looking at LS 3X Long's growth, its revenue over the trailing twelve months (TTM) was €7B. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.60%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns LS 3X Long stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.